已收录 273088 条政策
 政策提纲
  • 暂无提纲
ANTI-NOCICEPTIVE ACTIVITY OF CLONIXIN IN RHESUS MONKEYS
[摘要] References(9)Cited-By(4)Clonixin (Sch 10304) [2-(2' methyl-3' chloro anilino) nicotinic acid] has been reported to be an orally effective analgesic and a non-steroidal anti-inflammatory agent in rodents (1). Clonixin has no dependence liability in monkeys (2) and its analgesic effect is not antagonized by naloxone in mice and rats (3). Clinical results with clonixin have shown degrees of analgesic effects not usually observed with non-narcotic agents. Single oral doses of clonixin ranging from 300-600 mg produced pain relief comparable to that seen with parenteral administration of morphine (4). Procedures employing electric shock in monkeys have been used by other investigators for analgesic assessment (5-7). Thus far, only narcotic and narcotic antagonist analgesics have been shown to be effective in this procedure. This investigation describes the analgesic properties of clonixin on behavior maintained by nociceptive electric shock in Rhesus monkeys (Macaca mulatta) using a shock-escape procedure.
[发布日期]  [发布机构] 
[效力级别]  [学科分类] 药理学
[关键词]  [时效性] 
   浏览次数:2      统一登录查看全文      激活码登录查看全文